CMP Pharma develops, manufactures and commercializes specialty pharmaceuticals, focused on niche oral liquid. injectable and topical products that solve unmet patient needs. CMP manufactures CaroSpir® (Spironolactone Oral Suspension, 25 mg/5mL), the first and only FDA-approved oral suspension of the potassium-sparing diuretic spironolactone and the first and only FDA approved Potassium Phosphates Injection [15 mL Single-dose Glass Vial, 45 mM P (3 mM P/mL)] that will meet the critical demand for potassium phosphate while providing physicians and patients a safe alternative to using unapproved versions..